MAIA Biotechnology, Inc. MAIA
1.20
(0.05)
(4.00%)
as of 25 Sep
- Market cap
- $76.0M
- P/E
- 0.0×
Follow MAIA
Insider Buys
alert about insiders buying in the last 12 month
| Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|
Current Ratio |
4.63 | 0.44 | 4.97 | 3.61 | 1.53 | 2.65 | 1.66 |
Net Debt/EBITDA |
0.24 | 0.01 | 1.47 | 0.68 | 0.35 | 0.57 | 0.36 |
Debt/Assets |
2.03% | 79.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
(0.20) | (0.18) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.24 | 0.28 | 0.33 | 0.75 | 0.66 | 0.68 | 0.84 |
Capex/Depreciation |
— | — | 0.00 | — | — | — | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | 378.27% | (427.84%) | (183.39%) | (440.12%) | (1,131.04%) | (745.24%) | |
| 0.00% | (535.00%) | (207.13%) | (138.93%) | (201.88%) | (262.44%) | (225.54%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(477.45%) | 700.67% | (146.65%) | (189.95%) | (752.71%) | (367.81%) | (579.39%) |
Average Days of Receivables |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.15) | (0.17) | (0.78) | (1.30) | (0.99) | (0.71) | (0.59) |
Cash per Share |
0.16 | 0.06 | 2.00 | 1.18 | 0.54 | 0.43 | 0.27 |
Shareholders Equity per Share |
(0.02) | (0.31) | 1.74 | 0.92 | 0.04 | 0.16 | 0.07 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.02) | (0.31) | 1.74 | 0.92 | 0.04 | 0.16 | 0.07 |
Free Cash Flow |
(1.57) | (1.84) | (4.12) | (12.10) | (13.07) | (15.70) | (18.84) |
Working Capital |
1.36 | (0.95) | 8.53 | 8.54 | 2.63 | 6.32 | 3.87 |
Net Current Asset Value |
1.32 | (1.62) | 8.53 | 8.29 | 0.47 | 3.63 | 2.37 |
| Other line items | |||||||
Quick Ratio |
4.56 | 0.39 | 4.95 | 3.44 | 1.48 | 2.53 | 1.48 |
Depreciation/Fixed assets |
— | — | 0.00 | — | — | — | — |
Cash ROIC |
(99.57%) | 88.59% | (20.87%) | (62.16%) | (171.35%) | (118.65%) | (170.79%) |
Accounts Receivable Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | — |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.15) | (0.17) | (0.78) | (1.30) | (0.99) | (0.71) | (0.59) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | — | 0.17 | 0.22 | 0.11 | — |
Average Payables |
— | 0.19 | 0.58 | 1.06 | 1.40 | 1.58 | 1.78 |
Average Assets |
— | 1.24 | 6.04 | 11.67 | 9.79 | 8.86 | 9.93 |
Average Common Equity |
— | (1.75) | 2.92 | 8.84 | 4.49 | 2.06 | 3.01 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates